Medical Stocks To Follow Today - April 16th

UnitedHealth Group, Abbott Laboratories, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks refer to shares of companies operating within the health care sector, particularly those involved in the development, manufacturing, and distribution of medical equipment, pharmaceuticals, and other health-related products and services. They often attract investors due to innovations in medical technology and the regulatory impact on health care markets. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

UnitedHealth Group stock traded up $6.64 during trading hours on Wednesday, reaching $590.23. 1,988,622 shares of the company's stock traded hands, compared to its average volume of 4,331,626. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $539.89 billion, a price-to-earnings ratio of 38.08, a PEG ratio of 1.37 and a beta of 0.61. The firm's 50 day moving average is $514.87 and its 200-day moving average is $542.12. UnitedHealth Group has a fifty-two week low of $438.50 and a fifty-two week high of $630.73.

Read Our Latest Research Report on UNH

Abbott Laboratories (ABT)

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

Shares of ABT traded up $5.61 during midday trading on Wednesday, hitting $131.83. The stock had a trading volume of 7,243,272 shares, compared to its average volume of 6,036,929. Abbott Laboratories has a twelve month low of $99.71 and a twelve month high of $141.23. The company has a 50 day simple moving average of $130.62 and a two-hundred day simple moving average of $121.54. The firm has a market cap of $228.64 billion, a price-to-earnings ratio of 17.23, a price-to-earnings-growth ratio of 2.52 and a beta of 0.80. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.60 and a quick ratio of 1.14.

Read Our Latest Research Report on ABT

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

LLY traded down $18.64 during trading on Wednesday, reaching $738.54. 1,194,033 shares of the stock were exchanged, compared to its average volume of 3,378,586. Eli Lilly and Company has a twelve month low of $677.09 and a twelve month high of $972.53. The company has a debt-to-equity ratio of 2.00, a quick ratio of 0.97 and a current ratio of 1.15. The stock has a market cap of $700.26 billion, a P/E ratio of 63.07, a price-to-earnings-growth ratio of 1.40 and a beta of 0.51. The stock's 50 day moving average price is $832.96 and its two-hundred day moving average price is $821.54.

Read Our Latest Research Report on LLY